New JAMA study shows 98 % of EVALI sufferers bought products illegally

According to a newly released study, a substantial majority of 98 percent of hospitalized patients diagnosed with EVALI were found to have purchased their THC-containing products illegally.  Researchers further estimate that only one in 86 purchases between August 8, 2019 and the succeeding four months ending on November 8 were of legally manufactured and distributed products.

The study and its findings are based off medical data obtained from some 160 EVALI patients residing largely in California and who had histories of hospitalization due to contracting the disorder.  86 of the 160 patients also completed a standardized questionnaire which – after extensive analysis – provided the research team with deeper insights into the personal vaping habits, characteristics, and exposure levels of a typical patient. 

      • Age range of EVALI patients admitted into Intensive Care was 14 to 70 years with the median age being 27 years.
      • 74 percent were younger than 35 years.
      • 64 percent of the 160 patients were male
      • 46 percent of cases were admitted to Intensive Care.
      • 29 percent required mechanical ventilation
      • Four of the 160-patient control group died due to complications from their related lung injuries.

Related Article:   Dr. Siegel: CDC’s e-cig hysteria contributed to COVID death toll

Regarding the questionnaire specifically, participants were asked to provide responses based solely on their personal purchase histories of up to 90-days prior to being diagnosed with EVALI. Of the 86 patients who completed the questionnaire, 83 percent reported purchasing tetrahydrocannabinol (THC)-containing products. Of that percentage, most patients admitted that their purchases were made through “informal sources,” such as family members, friends, or non-verifiable dealers. 

CDC:  Nicotine-based vapes are NOT the cause of EVALI 


Another 43 percent of the original 160-member control group acknowledged a vaping preference for cannabidiol or CBD products, and 47 percent also reported engaging in dual use of nicotine-based vapes. The scientists from the California Department of Public Health (CADPH) who conducted the study were also able to itemize approximately 130 individual products purchased. 

Of the THC-infused brands, nearly all of them contained vitamin E acetate, which is a compound often used by black market suppliers to dilute the thicker THC-oils down to a vaporable concentration.  Unfortunately, vitamin E acetate is also the documented cause of EVALI, according to the U.S. Center for Disease Control and Prevention (CDC).  Conventional nicotine-based vapes have no direct link to EVALI.

      • Of the 130 products, 87 percent were THC-only (no nicotine).
      • 91 percent were prefilled cartridges or pod-style disposables like JUUL.
      • 56 of the THC-containing products also indicated flavorings ingredients on the product labels.
      • 25 were nicotine-only products.
      • Of those 24 nicotine-based vapes, only 48 were prefilled or pod styles. 76 percent contained additional flavorings.
      • The statistics would inevitably indicate that a whopping 98 percent of the 160 Intensive Care patients had purchased illegal products – either wittingly or unwittingly - through some sort of black market channel.

Related Article:   Prestigious medical journal endorses vaping as preventative to lung disease

After several months of misinformation spreading across social and mainstream media that warned of a newly discovered and potentially lethal respiratory disorder that was “vaping related”, the CDC was finally forced to publish the truth in a February, 26, 2020 press release.  Sadly, EVALI would go on to claim at least 60 deaths before  January 21, 2020, according to the CDC

“Due to continued declines in new EVALI cases since September 2019, and the identification of vitamin E acetate as a primary cause of EVALI, today’s release is the final biweekly CDC update on the number of hospitalized EVALI cases and deaths nationally. CDC will continue to provide assistance to states, as needed, related to EVALI and will provide future updates as needed at: www.cdc.gov/lunginjury.”

The newly published JAMA study is entitled Severe lung injury associated with use of e-cigarette, or vaping products—California, 2019  and is readily available via the Journal of the American Medical Association (JAMA).  The medical research and questionnaires analysis was conducted by a group of scientists from CADPH in coordination with the CDC.

Related Article:  With a whimper not a bang, CDC finally closes the case on ‘vaping related’ EVALI

(Images courtesy of Shutterstock)

Leave a comment

Please note, comments must be approved before they are published